Neuroscientists show how turning down synthesis of a protein improves nerve, muscle function in a common neuropathy. A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon. This research may also have relevance for other diseases that result from misfolded proteins, including Alzheimer’s disease, Parkinson’s, multiple sclerosis, Type 1 diabetes, cancer and mad cow disease.